• No results found

Macrophage regulatory mechanisms in atherosclerosis: The interplay of lipids and inflammation - Chapter 6: Myeloid Kdm6b disruption results in advanced atherosclerosis

N/A
N/A
Protected

Academic year: 2021

Share "Macrophage regulatory mechanisms in atherosclerosis: The interplay of lipids and inflammation - Chapter 6: Myeloid Kdm6b disruption results in advanced atherosclerosis"

Copied!
17
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

Macrophage regulatory mechanisms in atherosclerosis

The interplay of lipids and inflammation

Neele, A.E.

Publication date

2018

Document Version

Other version

License

Other

Link to publication

Citation for published version (APA):

Neele, A. E. (2018). Macrophage regulatory mechanisms in atherosclerosis: The interplay of

lipids and inflammation.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.

(2)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 107PDF page: 107PDF page: 107PDF page: 107

Chapter 6

Myeloid Kdm6b disruption results in

advanced atherosclerosis

Annette E. Neele, Marion J.J. Gijbels, Saskia van der Velden, Marten A. Hoeksema,

Marieke C.S. Boshuizen, Koen H.M. Prange, Jan Van den Bossche,Annelie Shami, Tina Lucas, Stefanie Dimmeler, Esther Lutgens, Menno P.J. de Winther

(3)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 108PDF page: 108PDF page: 108PDF page: 108

108

Abstract

Background and Aims: Atherosclerosis is lipid-driven chronic inflammatory disorder of

the arteries and monocytes and macrophages play a central role in this process. Within the atherosclerotic lesion macrophages can scavenge modified lipids and become so-called foam cells. We previously reported that the pro-fibrotic transcriptional profile of peritoneal foam cells is controlled by the epigenetic enzyme Kdm6b (also known as Jmjd3). Therefore, we studied the involvement of myeloid Kdm6b in atherosclerosis.

Material and Methods: Bone marrow of myeloid Kdm6b deficient (Kdm6bdel) mice or

wild type littermates (Kdm6bwt) was transplanted to lethally irradiated Ldlr-/- mice

which were fed a high fat diet for 9 weeks to induce atherosclerosis.

Results: Lesion size was similar between Kdm6bwt and Kdm6bdel transplanted mice.

However, lesions of Kdm6bdel mice contained more collagen and necrosis. Pathway analysis on peritoneal foam cells showed that the pathway involved in leukocyte chemotaxis was most significantly upregulated. Although macrophage and neutrophil content were similar after 9 weeks of high fat diet feeding, the relative increase in collagen content and necrosis revealed that atherosclerotic lesions in Kdm6bdel mice

progress faster.

Conclusion: Myeloid Kdm6b deficiency results in more advanced atherosclerosis.

109

Introduction

Atherosclerosis is a lipid-driven chronic inflammatory disorder of the arteries (1). Monocytes and macrophages play a key role in the initiation and progression of atherosclerotic lesions (1-3). Once monocytes enter the arterial wall and mature into macrophages, they can scavenge modified lipoproteins and thereby become foam cells (1). Besides having foam cell characteristics, macrophages can adopt different activation states based on their environmental triggers. Skewing macrophages to cells with anti-inflammatory features would be beneficial in chronic inflammatory diseases like atherosclerosis (4-6). This can be accomplished by targeting epigenetic processes in macrophages since these are critical for monocyte and macrophage activation (7, 8). Histone modifications are one of the central epigenetic mechanisms of gene regulation referring to posttranslational modifications at histone tails. Histone H3K27 trimethylation is a repressive histone mark catalyzed by the polycomb repressive complex 2 (PRC2) (9) and can be removed by the demethylases Jumonji-C domain 3 (Kdm6b; Jmjd3), Ubiquitously-Transcribed X Chromosome Tetratricopeptide Repeat Protein (Utx) and Ubiquitously-Transcribed Y Chromosome Tetratricopeptide Repeat Protein (Uty) (10). The role of these demethylases in macrophage polarization has been extensively studied and Kdm6b is regulated in response to numeral triggers regulating both inflammatory and anti-inflammatory responses (11-18). We previously reported that peritoneal foam cells from Kdm6b deficient mice, have reduced expression of pro-fibrotic genes and pathways (19). Fibrosis is also important in atherosclerosis. Advanced atherosclerotic lesions are characterized by a fibrous cap which is mainly built of smooth muscle cells and collagen (20). Giving the fact that atherosclerosis is driven by immune cells like macrophages, and upon lesion progression a fibrous cap is built, we studied the involvement of myeloid Kdm6b in atherosclerosis. We found that atherosclerotic lesions of Kdm6b deficient mice were more advanced as they contained more collagen and exhibited more necrosis.

Materials and Methods

Atherosclerosis experiment

For our experiments we made use of C57BL/6 low density lipoprotein receptor knock out mice (Ldlr-/-) since these mice are prone to develop atherosclerosis. Ldlr−/− mice

were obtained from Jackson laboratories. A bone marrow transplantation (BMT) was performed with either LysM-cre+ Kdm6bfl/fl mice (Kdm6bdel) or LysM-cre- Kdm6bfl/fl

(4)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 109PDF page: 109PDF page: 109PDF page: 109

108

Abstract

Background and Aims: Atherosclerosis is lipid-driven chronic inflammatory disorder of

the arteries and monocytes and macrophages play a central role in this process. Within the atherosclerotic lesion macrophages can scavenge modified lipids and become so-called foam cells. We previously reported that the pro-fibrotic transcriptional profile of peritoneal foam cells is controlled by the epigenetic enzyme Kdm6b (also known as Jmjd3). Therefore, we studied the involvement of myeloid Kdm6b in atherosclerosis.

Material and Methods: Bone marrow of myeloid Kdm6b deficient (Kdm6bdel) mice or

wild type littermates (Kdm6bwt) was transplanted to lethally irradiated Ldlr-/- mice

which were fed a high fat diet for 9 weeks to induce atherosclerosis.

Results: Lesion size was similar between Kdm6bwt and Kdm6bdel transplanted mice.

However, lesions of Kdm6bdel mice contained more collagen and necrosis. Pathway analysis on peritoneal foam cells showed that the pathway involved in leukocyte chemotaxis was most significantly upregulated. Although macrophage and neutrophil content were similar after 9 weeks of high fat diet feeding, the relative increase in collagen content and necrosis revealed that atherosclerotic lesions in Kdm6bdel mice

progress faster.

Conclusion: Myeloid Kdm6b deficiency results in more advanced atherosclerosis.

109

Introduction

Atherosclerosis is a lipid-driven chronic inflammatory disorder of the arteries (1). Monocytes and macrophages play a key role in the initiation and progression of atherosclerotic lesions (1-3). Once monocytes enter the arterial wall and mature into macrophages, they can scavenge modified lipoproteins and thereby become foam cells (1). Besides having foam cell characteristics, macrophages can adopt different activation states based on their environmental triggers. Skewing macrophages to cells with anti-inflammatory features would be beneficial in chronic inflammatory diseases like atherosclerosis (4-6). This can be accomplished by targeting epigenetic processes in macrophages since these are critical for monocyte and macrophage activation (7, 8). Histone modifications are one of the central epigenetic mechanisms of gene regulation referring to posttranslational modifications at histone tails. Histone H3K27 trimethylation is a repressive histone mark catalyzed by the polycomb repressive complex 2 (PRC2) (9) and can be removed by the demethylases Jumonji-C domain 3 (Kdm6b; Jmjd3), Ubiquitously-Transcribed X Chromosome Tetratricopeptide Repeat Protein (Utx) and Ubiquitously-Transcribed Y Chromosome Tetratricopeptide Repeat Protein (Uty) (10). The role of these demethylases in macrophage polarization has been extensively studied and Kdm6b is regulated in response to numeral triggers regulating both inflammatory and anti-inflammatory responses (11-18). We previously reported that peritoneal foam cells from Kdm6b deficient mice, have reduced expression of pro-fibrotic genes and pathways (19). Fibrosis is also important in atherosclerosis. Advanced atherosclerotic lesions are characterized by a fibrous cap which is mainly built of smooth muscle cells and collagen (20). Giving the fact that atherosclerosis is driven by immune cells like macrophages, and upon lesion progression a fibrous cap is built, we studied the involvement of myeloid Kdm6b in atherosclerosis. We found that atherosclerotic lesions of Kdm6b deficient mice were more advanced as they contained more collagen and exhibited more necrosis.

Materials and Methods

Atherosclerosis experiment

For our experiments we made use of C57BL/6 low density lipoprotein receptor knock out mice (Ldlr-/-) since these mice are prone to develop atherosclerosis. Ldlr−/− mice

were obtained from Jackson laboratories. A bone marrow transplantation (BMT) was performed with either LysM-cre+ Kdm6bfl/fl mice (Kdm6bdel) or LysM-cre- Kdm6bfl/fl

littermates (Kdm6bwt). Kdm6bfl/fl mice were kindly provided by the laboratory of

(5)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 110PDF page: 110PDF page: 110PDF page: 110

110

Stefanie Dimmeler (21). Crossbreeding with LysM-cre was performed in our mice facility. Briefly, 40 (20 per group), 10-week old female Ldlr-/- mice were divided over

filter-top cages and provided antibiotics water (neomycin (100 mg/L, Sigma, Zwijndrecht, the Netherlands) and polymyxin B sulfate (60,000 U/L, Invitrogen, Bleiswijk, The Netherlands)) from 1 week pre-BMT until 5 weeks post-BMT. The animals received 2 x 6 Gy total body irradiation on two consecutive days. Bone marrow was isolated from two Kdm6bdel and two Kdm6bwt mice, resuspended in

RPMI1640 (Gibco, Breda, The Netherlands) with 5 U/ml heparin and 2 % iFCS (Gibco, Breda, the Netherlands), and 5*106 cells were injected intravenously per irradiated

mouse. Bone marrow transplantation efficiency was determined with qPCR for the Ldlr on DNA isolated from blood (GE Healthcare, Eindhoven, the Netherlands). Three mice were excluded from the analysis due to inefficient bone marrow transplantation (≤80 %). Five weeks after the BMT, the mice were put on a high fat diet (0.15 % cholesterol, 16 % fat, Arie Blok Diets, The Netherlands) for 9 weeks. After sacrifice, hearts were taken out and frozen in Tissue-Tek (DAKO, Eindhoven, The Netherlands) for histology. Blood samples were taken before the start of the diet and before sacrifice for lipid profiling and immune cell flow cytometry. Two mice were sacrificed before the end of experiment since they reached the human endpoints. One additional mice was excluded from the analysis due to insufficient tissue quality. A final of 16 Kdm6bdel

mice were compared to 18 Kdm6bwt mice for the statistical analysis. All animal

experiments were conducted at the University of Amsterdam and approved (permit: DBC10AD) by the Committee for Animal Welfare of the Academic Medical Center, University of Amsterdam.

Histochemistry

Atherosclerotic lesions from the heart were cut in sections of 7 μm on a Leica 3050 cryostat at −25 °C. Cross sections of every 42 μm were stained with Toluidin Blue (0.2 % in PBS, Sigma-Aldrich, Gillingham, UK) to determine lesion size. Lesion size was measured by use of adobe photoshop CS4 and the sum of the three valves is presented. Lesion severity was scored by an experienced pathologist as early (intimal xanthoma), moderate (pathological intimal thickening) and advanced (fibrous cap atheroma) as described elsewhere (22). Sirius red staining was performed for 30 minutes to measure collagen content (0.05 % direct Red in saturated picric acid, Sigma, Zwijndrecht, the Nederlands). Images were obtained using a Leica DM3000 microscope and quantified with photoshop CS4 where collagen quantified as the percentage of total lesion size. Cap thickness was defined as the thinnest part of where cap is visible. For immunohistochemistry slides were fixed in aceton and blocked with Avidin/Biotin Blocking Kit (Vector Laboratories, Burlingame, USA).

111

Herafter cells were incubated with MOMA-2 (1:4000, AbD serotec, Uden, the Netherlands) to stain for macrophages. Biotin-labeled rabbit anti–rat antibody (1:300, Dako, Eindhoven, the Netherlands) was used as a secondary antibody. The signal was amplified using ABC kit (Vector Laboratories, Burlingame, USA) and visualized with the AEC kit (Vector Laboratories, Burlingame, USA). Necrosis area was measured based on toluidin Blue staining by our pathologist and corrected for total plaque size. The EnzChek gelatinase assay kit was used to measure gelatinase activity (Molecular Probes, ThermoFisher scientific, Waltham, MA, USA). Briefly, the slides were fixed with 100 % ethanol for 20 minutes. Next, the slides were incubated with the gelatin solution in a final concentration of 20 µg/ml covered with parafilm and incubated in a moister box for 2 hours at 37 °C. To stop the reaction, samples were fixed in 3.7 % formaldehyde for 10 minutes and stained with DAPI for 5 minutes. Fluorescence images were obtained using a Leica DM3000 microscope and quantified with photoshop CS4. Gelatinase activity (green fluorescence) was corrected for total plaque size.

Bone marrow-derived macrophage culture and collagen synthesis by VSMCs

Bone marrow was isolated from femurs and tibias of Kdm6bwt and Kdm6bdel mice by

flushing. The cells were cultured in RPMI-1640 with 25mM HEPES and 2mM L-glutamine which was supplemented with 10 % FCS, penicillin (100 U/ml), streptomycin (100 µg/ml) and 15 % L929-conditioned medium as a source of M-CSF for 8 days. On day 8, cells were stimulated with 50 µg/ml oxLDL, 50 µg/ml acLDL (Alfa Aesar, Karlsruhe, Germany) or left unstimulated for 24 hours. Supernatants were collected and used for the collagen production by vascular smooth muscle cells (VSMCs) assays. Primary mouse VSMCs were isolated and cultured in DMEM/F12 with 20 % FCS (Gibco) on 0.1 % gelatin coated plates. 5*104 VSMCs were plated per well in a gelatin-coated

24-wells plate. After overnight adherence, cells were starved (0 % FCS) for 48 hours and next incubated with bone marrow-derived macrophage (BMDM) supernatants for 24 hours. Hereafter the supernatant was removed and VSMCs were fixed in 3.7% formaldehyde and stained with 1 % Sirius Red in 0.01 M HCl. Cells were lysed with 0.01 M NaOH and absorption was measured on a plate reader at 544nm. Gelatin was used as a standard for quantification.

Peritoneal macrophages

Four days prior to the sacrifice five mice per group (Kdm6bwt or Kdm6bdel) were

injected intraperitoneally with thioglycollate medium (3%, Fisher, Bleiswijk, The Netherlands) as published (19).

(6)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 111PDF page: 111PDF page: 111PDF page: 111

110

Stefanie Dimmeler (21). Crossbreeding with LysM-cre was performed in our mice facility. Briefly, 40 (20 per group), 10-week old female Ldlr-/- mice were divided over

filter-top cages and provided antibiotics water (neomycin (100 mg/L, Sigma, Zwijndrecht, the Netherlands) and polymyxin B sulfate (60,000 U/L, Invitrogen, Bleiswijk, The Netherlands)) from 1 week pre-BMT until 5 weeks post-BMT. The animals received 2 x 6 Gy total body irradiation on two consecutive days. Bone marrow was isolated from two Kdm6bdel and two Kdm6bwt mice, resuspended in

RPMI1640 (Gibco, Breda, The Netherlands) with 5 U/ml heparin and 2 % iFCS (Gibco, Breda, the Netherlands), and 5*106 cells were injected intravenously per irradiated

mouse. Bone marrow transplantation efficiency was determined with qPCR for the Ldlr on DNA isolated from blood (GE Healthcare, Eindhoven, the Netherlands). Three mice were excluded from the analysis due to inefficient bone marrow transplantation (≤80 %). Five weeks after the BMT, the mice were put on a high fat diet (0.15 % cholesterol, 16 % fat, Arie Blok Diets, The Netherlands) for 9 weeks. After sacrifice, hearts were taken out and frozen in Tissue-Tek (DAKO, Eindhoven, The Netherlands) for histology. Blood samples were taken before the start of the diet and before sacrifice for lipid profiling and immune cell flow cytometry. Two mice were sacrificed before the end of experiment since they reached the human endpoints. One additional mice was excluded from the analysis due to insufficient tissue quality. A final of 16 Kdm6bdel

mice were compared to 18 Kdm6bwt mice for the statistical analysis. All animal

experiments were conducted at the University of Amsterdam and approved (permit: DBC10AD) by the Committee for Animal Welfare of the Academic Medical Center, University of Amsterdam.

Histochemistry

Atherosclerotic lesions from the heart were cut in sections of 7 μm on a Leica 3050 cryostat at −25 °C. Cross sections of every 42 μm were stained with Toluidin Blue (0.2 % in PBS, Sigma-Aldrich, Gillingham, UK) to determine lesion size. Lesion size was measured by use of adobe photoshop CS4 and the sum of the three valves is presented. Lesion severity was scored by an experienced pathologist as early (intimal xanthoma), moderate (pathological intimal thickening) and advanced (fibrous cap atheroma) as described elsewhere (22). Sirius red staining was performed for 30 minutes to measure collagen content (0.05 % direct Red in saturated picric acid, Sigma, Zwijndrecht, the Nederlands). Images were obtained using a Leica DM3000 microscope and quantified with photoshop CS4 where collagen quantified as the percentage of total lesion size. Cap thickness was defined as the thinnest part of where cap is visible. For immunohistochemistry slides were fixed in aceton and blocked with Avidin/Biotin Blocking Kit (Vector Laboratories, Burlingame, USA).

111

Herafter cells were incubated with MOMA-2 (1:4000, AbD serotec, Uden, the Netherlands) to stain for macrophages. Biotin-labeled rabbit anti–rat antibody (1:300, Dako, Eindhoven, the Netherlands) was used as a secondary antibody. The signal was amplified using ABC kit (Vector Laboratories, Burlingame, USA) and visualized with the AEC kit (Vector Laboratories, Burlingame, USA). Necrosis area was measured based on toluidin Blue staining by our pathologist and corrected for total plaque size. The EnzChek gelatinase assay kit was used to measure gelatinase activity (Molecular Probes, ThermoFisher scientific, Waltham, MA, USA). Briefly, the slides were fixed with 100 % ethanol for 20 minutes. Next, the slides were incubated with the gelatin solution in a final concentration of 20 µg/ml covered with parafilm and incubated in a moister box for 2 hours at 37 °C. To stop the reaction, samples were fixed in 3.7 % formaldehyde for 10 minutes and stained with DAPI for 5 minutes. Fluorescence images were obtained using a Leica DM3000 microscope and quantified with photoshop CS4. Gelatinase activity (green fluorescence) was corrected for total plaque size.

Bone marrow-derived macrophage culture and collagen synthesis by VSMCs

Bone marrow was isolated from femurs and tibias of Kdm6bwt and Kdm6bdel mice by

flushing. The cells were cultured in RPMI-1640 with 25mM HEPES and 2mM L-glutamine which was supplemented with 10 % FCS, penicillin (100 U/ml), streptomycin (100 µg/ml) and 15 % L929-conditioned medium as a source of M-CSF for 8 days. On day 8, cells were stimulated with 50 µg/ml oxLDL, 50 µg/ml acLDL (Alfa Aesar, Karlsruhe, Germany) or left unstimulated for 24 hours. Supernatants were collected and used for the collagen production by vascular smooth muscle cells (VSMCs) assays. Primary mouse VSMCs were isolated and cultured in DMEM/F12 with 20 % FCS (Gibco) on 0.1 % gelatin coated plates. 5*104 VSMCs were plated per well in a gelatin-coated

24-wells plate. After overnight adherence, cells were starved (0 % FCS) for 48 hours and next incubated with bone marrow-derived macrophage (BMDM) supernatants for 24 hours. Hereafter the supernatant was removed and VSMCs were fixed in 3.7% formaldehyde and stained with 1 % Sirius Red in 0.01 M HCl. Cells were lysed with 0.01 M NaOH and absorption was measured on a plate reader at 544nm. Gelatin was used as a standard for quantification.

Peritoneal macrophages

Four days prior to the sacrifice five mice per group (Kdm6bwt or Kdm6bdel) were

injected intraperitoneally with thioglycollate medium (3%, Fisher, Bleiswijk, The Netherlands) as published (19).

(7)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 112PDF page: 112PDF page: 112PDF page: 112

112

Flow cytometry

150 μl of blood was withdrawn from mice via tail vein incision before the start of the diet, five weeks after the diet and right before sacrifice and added to 20 μl of 0,5 M EDTA (Sigma-Aldrich, Gillingham, UK). Blood was withdrawn from mice which were restricted from food for at least 4 hours. The blood was centrifuged (10 min, 4°C, 2000 rpm) to separate the plasma from blood cells and plasma cholesterol and triglyceride levels were enzymatically measured according to the manufacturer's protocol (Roche, Woerden, The Netherlands). Blood was further used for flow cytometry to assess relative leukocyte counts. Red blood cells were lysed by adding 5 ml of erythrocyte lysis buffer (8.4 g of NH4Cl, 0.84 g of NaHCO3 and 0.37 g EDTA) for 15 min at RT. PBS

was added to stop the reaction and cells were spun down. White blood cells were used for flow cytometry. First Fc receptors were blocked with CD16/CD32 blocking antibody (1:100, eBioscience) in FACS buffer (0.5% BSA, 0.01% NaN3 in PBS). Hereafter

cells were incubated with the appropriate antibodies for 30 min at RT (table 1). Cells were washed once and resuspended in FACS buffer. Fluorescence was measured with a BD Canto II and analyzed with FlowJo software. Live cells were gated based on CD45+ expression and the following cell types were distinguished: Monocytes (CD11b+ and Ly6G-), neutrophils (CD11b+ and Ly6G+), B cells (CD19+), and T cells (CD3+).

Antibody Dilution Supplier

CD45 (APC-Cy7) 1:100 Biolegend

CD11b (FITC) 1:100 eBioscience

Ly6G (PE) 1:200 Biolegend

CD19 (PerCp Cy5.5) 1:100 eBioscience

CD3 (FITC) 1:100 eBioscience

Table 1: Antibody specifications

RNA isolation and quantitative PCR analysis

RNA from peritoneal macrophages was isolated with High Pure RNA Isolation kits (Roche, Basel, Switzerland) from 500,000 cells as described and used in our previous study (19). RNA from aortic arches was isolated with the Rneasy mini column kit (Qiagen, Venlo, The Netherlands). 400 ng (PEMs) or 200 ng (aortic arch) of RNA was used for cDNA synthesis with iScript (BioRad, Veenendaal, The Netherlands). qPCR was performed with 4 ng cDNA using Sybr Green Fast on a ViiA7 PCR machine (Applied Biosystems, Bleiswijk, The Netherlands). All genes were normalized to the mean of the two housekeeping genes Ppia and Rplp0. Primer sequences are available on request.

113

RNA sequencing and Bioinformatic analysis

RNA from unstimulated Kdm6bwt and Kdm6bdel peritoneal foam cells was used for RNA

sequencing as previously published (19). Bioinformatic analysis was performed as described before (19). Gene expression was called as differential with a multiple testing (Bonferroni) adjusted P < 0.05 and an average RPKM >1 in at least one group.

Statistical analysis

Data represent the mean ± standard error of the mean (SEM). Differences between Kdm6bwt and Kdm6bdel transplanted mice are analyzed using a unpaired student’s

t-test or a two-way ANOVA using bonferroni post-hoc t-test analysis for grouped analysis. P-Values <0.05 were considered statistically significant. Data were analyzed using Prism version 5.0 (GraphPad software, La Jolla, California).

Results

Bone marrow of Kdm6bwt and Kdm6bdel mice was effectively transplanted to Ldlr

-/-mice

To study the involvement of macrophage Kdm6b in atherosclerosis, bone marrow of Kdm6bwt (Cre-) or Kdm6bdel (Cre+) mice was transplanted to irradiated Ldlr-/- mice.

After reconstitution of the bone marrow, chimeras were fed a high fat diet (HFD) for nine weeks to induce atherosclerosis. The transplanted bone marrow was efficiently reconstituted in both Kdm6bwt and Kdm6bdel transplanted mice (Figure 1A). Weight

gain was similar after nine weeks of HFD (Figure 1B). A small but significant decrease in cholesterol and triglyceride levels was observed in Kdm6bdel transplanted mice after

nine weeks, but not after five weeks of diet (Figure 1C-D). This had no effect on the leukocyte composition in the blood as measured by flow cytometry (Figure 1E). Thioglycollate elucidated peritoneal macrophages were isolated and studied ex vivo as previously reported (19). Kdm6b gene expression in peritoneal foam cells was significantly reduced in Kdm6bdel transplanted mice, indicating efficient deletion of

(8)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 113PDF page: 113PDF page: 113PDF page: 113

112

Flow cytometry

150 μl of blood was withdrawn from mice via tail vein incision before the start of the diet, five weeks after the diet and right before sacrifice and added to 20 μl of 0,5 M EDTA (Sigma-Aldrich, Gillingham, UK). Blood was withdrawn from mice which were restricted from food for at least 4 hours. The blood was centrifuged (10 min, 4°C, 2000 rpm) to separate the plasma from blood cells and plasma cholesterol and triglyceride levels were enzymatically measured according to the manufacturer's protocol (Roche, Woerden, The Netherlands). Blood was further used for flow cytometry to assess relative leukocyte counts. Red blood cells were lysed by adding 5 ml of erythrocyte lysis buffer (8.4 g of NH4Cl, 0.84 g of NaHCO3 and 0.37 g EDTA) for 15 min at RT. PBS

was added to stop the reaction and cells were spun down. White blood cells were used for flow cytometry. First Fc receptors were blocked with CD16/CD32 blocking antibody (1:100, eBioscience) in FACS buffer (0.5% BSA, 0.01% NaN3 in PBS). Hereafter

cells were incubated with the appropriate antibodies for 30 min at RT (table 1). Cells were washed once and resuspended in FACS buffer. Fluorescence was measured with a BD Canto II and analyzed with FlowJo software. Live cells were gated based on CD45+ expression and the following cell types were distinguished: Monocytes (CD11b+ and Ly6G-), neutrophils (CD11b+ and Ly6G+), B cells (CD19+), and T cells (CD3+).

Antibody Dilution Supplier

CD45 (APC-Cy7) 1:100 Biolegend

CD11b (FITC) 1:100 eBioscience

Ly6G (PE) 1:200 Biolegend

CD19 (PerCp Cy5.5) 1:100 eBioscience

CD3 (FITC) 1:100 eBioscience

Table 1: Antibody specifications

RNA isolation and quantitative PCR analysis

RNA from peritoneal macrophages was isolated with High Pure RNA Isolation kits (Roche, Basel, Switzerland) from 500,000 cells as described and used in our previous study (19). RNA from aortic arches was isolated with the Rneasy mini column kit (Qiagen, Venlo, The Netherlands). 400 ng (PEMs) or 200 ng (aortic arch) of RNA was used for cDNA synthesis with iScript (BioRad, Veenendaal, The Netherlands). qPCR was performed with 4 ng cDNA using Sybr Green Fast on a ViiA7 PCR machine (Applied Biosystems, Bleiswijk, The Netherlands). All genes were normalized to the mean of the two housekeeping genes Ppia and Rplp0. Primer sequences are available on request.

113

RNA sequencing and Bioinformatic analysis

RNA from unstimulated Kdm6bwt and Kdm6bdel peritoneal foam cells was used for RNA

sequencing as previously published (19). Bioinformatic analysis was performed as described before (19). Gene expression was called as differential with a multiple testing (Bonferroni) adjusted P < 0.05 and an average RPKM >1 in at least one group.

Statistical analysis

Data represent the mean ± standard error of the mean (SEM). Differences between Kdm6bwt and Kdm6bdel transplanted mice are analyzed using a unpaired student’s

t-test or a two-way ANOVA using bonferroni post-hoc t-test analysis for grouped analysis. P-Values <0.05 were considered statistically significant. Data were analyzed using Prism version 5.0 (GraphPad software, La Jolla, California).

Results

Bone marrow of Kdm6bwt and Kdm6bdel mice was effectively transplanted to Ldlr

-/-mice

To study the involvement of macrophage Kdm6b in atherosclerosis, bone marrow of Kdm6bwt (Cre-) or Kdm6bdel (Cre+) mice was transplanted to irradiated Ldlr-/- mice.

After reconstitution of the bone marrow, chimeras were fed a high fat diet (HFD) for nine weeks to induce atherosclerosis. The transplanted bone marrow was efficiently reconstituted in both Kdm6bwt and Kdm6bdel transplanted mice (Figure 1A). Weight

gain was similar after nine weeks of HFD (Figure 1B). A small but significant decrease in cholesterol and triglyceride levels was observed in Kdm6bdel transplanted mice after

nine weeks, but not after five weeks of diet (Figure 1C-D). This had no effect on the leukocyte composition in the blood as measured by flow cytometry (Figure 1E). Thioglycollate elucidated peritoneal macrophages were isolated and studied ex vivo as previously reported (19). Kdm6b gene expression in peritoneal foam cells was significantly reduced in Kdm6bdel transplanted mice, indicating efficient deletion of

Kdm6b (Figure 1F).

(9)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 114PDF page: 114PDF page: 114PDF page: 114

114

Figure 1: Bone marrow of Kdm6bwt and Kdm6bdel mice was effectively transplanted to Ldlr-/- mice. (A) Chimerism determination by qPCR for the Ldlr-/- in the DNA of blood of Kdm6bwt (black) and Kdm6bdel (white) transplanted mice. (B) Mouse weight in grams at the start of the diet (week 0) and after 9 weeks of high fat diet. (C) Triglyceride and (D) cholesterol levels in the plasma at the start (week 0), middle (week 5), and end of the

diet (week 9). (E) Percentage of blood leukocyte subsets assessed by flow cytometry. (F) Kdm6b mRNA

expression in peritoneal foam cells. n=16-18/group. Data represent mean ± SEM *P<0.05; **P<0.01; ***P<0.001.

Macrophage Kdm6b disruption alters collagen deposition in atherosclerotic lesions of mice

We found that myeloid Kdm6b deficiency does not alter atherosclerotic lesion size after nine weeks of HFD (Figure 2A-B). Plaque phenotype analysis indicated a small but non-significant effect on plaque severity. Kdm6bdel mice had less intimal xanthoma’s and more fibrous cap atheroma’s compared to Kdm6bwt mice, indicating that the

lesions are more advanced in Kdm6bdel transplanted mice (Figure 2C). Pathology

scoring also revealed that collagen content was significantly higher in the Kdm6bdel

transplanted mice compared to wildtype (Figure 2D). Collagen staining by Sirius red on the atherosclerotic lesions confirmed a significant increase in the collagen content of atherosclerotic lesions in Kdm6bdel transplanted mice (Figure 2E-F). In addition,

minimal cap thickness was also increased by approximately 2-fold (Figure 2G). Macrophage and neutrophil content of the plaques was unaltered (Figure 2H-I and data not shown) but necrotic area was enhanced in Kdm6bdel transplanted mice

(Figure 2J-K). These data indicate that atherosclerotic lesions of Kdm6bdel transplanted

mice are similar in size but have a more advanced phenotype.

115

Figure 2: Myeloid Kdm6b deficiency results in advanced atherosclerotic lesions. (A) Representative toluidine

blue staining of the aortic root of Kdm6bwt and Kdm6bdel transplanted mice (B) Aortic lesion area presented as the sum of the three valves per mice (C) Plaque severity scoring by a pathologist (D) Collagen scoring by a

pathologist scoring from few (-) to many (++++). P-value is calculated by a Chi-Square test. (E) Representative

Sirius Red staining to measure collagen. (F) Collagen content as percentage of total lesion area. (G) Minimal cap

thickness in µm measured at the thinnest region of the fibrous cap. (H) Representative MOMA-2 staining for

macrophages. (I) Macrophage area as percentage of total lesion area. (J) Necrotic core area indicated in red on

the toluidine blue staining. (K) Necrotic core are as percentage of total lesion area. Data represent mean ± SEM

*P<0.05; **P<0.01; ***P<0.001.

No clear macrophage phenotype is responsible for the increase in collagen content

Atherosclerotic lesions of Kdm6bdel mice have increased collagen content. In contrast,

pathway analysis previously revealed that pro-fibrotic pathways were downregulated (19). We next assessed the expression of other candidate genes in these foam cells involved in collagen synthesis and breakdown. The expression of transforming growth factor beta (Tgfb1) was slightly enhanced in Kdm6bdel peritoneal foam cells (Figure 3A). Metalloproteinases are responsible for the degradation of collagen and we found

(10)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 115PDF page: 115PDF page: 115PDF page: 115

114

Figure 1: Bone marrow of Kdm6bwt and Kdm6bdel mice was effectively transplanted to Ldlr-/- mice. (A) Chimerism determination by qPCR for the Ldlr-/- in the DNA of blood of Kdm6bwt (black) and Kdm6bdel (white) transplanted mice. (B) Mouse weight in grams at the start of the diet (week 0) and after 9 weeks of high fat diet. (C) Triglyceride and (D) cholesterol levels in the plasma at the start (week 0), middle (week 5), and end of the

diet (week 9). (E) Percentage of blood leukocyte subsets assessed by flow cytometry. (F) Kdm6b mRNA

expression in peritoneal foam cells. n=16-18/group. Data represent mean ± SEM *P<0.05; **P<0.01; ***P<0.001.

Macrophage Kdm6b disruption alters collagen deposition in atherosclerotic lesions of mice

We found that myeloid Kdm6b deficiency does not alter atherosclerotic lesion size after nine weeks of HFD (Figure 2A-B). Plaque phenotype analysis indicated a small but non-significant effect on plaque severity. Kdm6bdel mice had less intimal xanthoma’s and more fibrous cap atheroma’s compared to Kdm6bwt mice, indicating that the

lesions are more advanced in Kdm6bdel transplanted mice (Figure 2C). Pathology

scoring also revealed that collagen content was significantly higher in the Kdm6bdel

transplanted mice compared to wildtype (Figure 2D). Collagen staining by Sirius red on the atherosclerotic lesions confirmed a significant increase in the collagen content of atherosclerotic lesions in Kdm6bdel transplanted mice (Figure 2E-F). In addition,

minimal cap thickness was also increased by approximately 2-fold (Figure 2G). Macrophage and neutrophil content of the plaques was unaltered (Figure 2H-I and data not shown) but necrotic area was enhanced in Kdm6bdel transplanted mice

(Figure 2J-K). These data indicate that atherosclerotic lesions of Kdm6bdel transplanted

mice are similar in size but have a more advanced phenotype.

115

Figure 2: Myeloid Kdm6b deficiency results in advanced atherosclerotic lesions. (A) Representative toluidine

blue staining of the aortic root of Kdm6bwt and Kdm6bdel transplanted mice (B) Aortic lesion area presented as the sum of the three valves per mice (C) Plaque severity scoring by a pathologist (D) Collagen scoring by a

pathologist scoring from few (-) to many (++++). P-value is calculated by a Chi-Square test. (E) Representative

Sirius Red staining to measure collagen. (F) Collagen content as percentage of total lesion area. (G) Minimal cap

thickness in µm measured at the thinnest region of the fibrous cap. (H) Representative MOMA-2 staining for

macrophages. (I) Macrophage area as percentage of total lesion area. (J) Necrotic core area indicated in red on

the toluidine blue staining. (K) Necrotic core are as percentage of total lesion area. Data represent mean ± SEM

*P<0.05; **P<0.01; ***P<0.001.

No clear macrophage phenotype is responsible for the increase in collagen content

Atherosclerotic lesions of Kdm6bdel mice have increased collagen content. In contrast,

pathway analysis previously revealed that pro-fibrotic pathways were downregulated (19). We next assessed the expression of other candidate genes in these foam cells involved in collagen synthesis and breakdown. The expression of transforming growth factor beta (Tgfb1) was slightly enhanced in Kdm6bdel peritoneal foam cells (Figure 3A). Metalloproteinases are responsible for the degradation of collagen and we found

(11)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 116PDF page: 116PDF page: 116PDF page: 116

116

Mmp2 to be reduced in foam cells of Kdm6bdel mice. Mmp9, Mmp12 and Mmp13

were unaltered (Figure 3B). Tissue inhibitor of metalloproteinases (Timps) are inhibitors of the Mmps and Timp3 was reduced in Kdm6b deficient peritoneal foam cells (Figure 3C). Nevertheless, expression of Tgfb1, Mmp2 and Timp3 in the aortic arch was unaltered between Kdm6bwt and Kdm6bdel transplanted mice (Figure 3D-F). Furthermore, collagen production ex vivo by vascular smooth muscle cells (VSMCs) treated with supernatants of Kdm6bwt and Kdm6bdel stimulated BMDMs was

unaffected by Kdm6b deficiency (Figure 3G). Next we assessed if the difference in collagen was due to changes in degradation rather that the synthesis of collagen. We performed zymopgraphy staining on the aortic lesions which measures gelatinase activity (mainly Mmp2 and Mmp9). No difference in gelatinase activity was observed between both groups (Figure 3H).

Figure 3: Peritoneal macrophages of Kdm6b deleted mice express more Tgfb1. Relative mRNA expression in

unstimulated PEMs of (A)Tgfb1 (B) Mmps and (C) Timps. Relative mRNA expression of (D) Tgfb1 (E) Mmp2 and (F) Timp3 in aortic arches of mice. Expression levels were normalized to two housekeeping genes. (G) Collagen

production by VSMCs incubated for 24h with supernatants of Kdm6bwt or Kdm6bdel BMDMs. BMDMs were stimulated for 24h with oxLDL or acLDL (both 50ug/ml) or left unstimulated. (H) Gelatinase activity as

percentage of total lesion area. Data represent mean ± SEM *P<0.05; **P<0.01; ***P<0.001.

117

Figure 4: Leukocyte chemotaxis pathway is upregulated in Kdm6bdel mice. (A) Heatmap of significantly up- and downregulated genes in unstimulated Kdm6bwt and Kdm6bdel foam cells based on RNA sequencing analysis. Bonferroni adjusted p < 0.05 and RPKM >1 in at least one group. (B) Significantly upregulated genes in Kdm6b

deficient foam cells compared with Kdm6bwt cells. (C) Top 10 pathways and GO-terms of upregulated genes from (B) RPKM: Reads per kilobase per million mapped reads.

Pathway analysis shows upregulation of leukocyte chemotaxis

Since the mechanism by which myeloid kdm6b contributes to lesion development remained indefinite, we performed pathway analysis on upregulated genes of kdm6b

(12)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 117PDF page: 117PDF page: 117PDF page: 117

116

Mmp2 to be reduced in foam cells of Kdm6bdel mice. Mmp9, Mmp12 and Mmp13

were unaltered (Figure 3B). Tissue inhibitor of metalloproteinases (Timps) are inhibitors of the Mmps and Timp3 was reduced in Kdm6b deficient peritoneal foam cells (Figure 3C). Nevertheless, expression of Tgfb1, Mmp2 and Timp3 in the aortic arch was unaltered between Kdm6bwt and Kdm6bdel transplanted mice (Figure 3D-F). Furthermore, collagen production ex vivo by vascular smooth muscle cells (VSMCs) treated with supernatants of Kdm6bwt and Kdm6bdel stimulated BMDMs was

unaffected by Kdm6b deficiency (Figure 3G). Next we assessed if the difference in collagen was due to changes in degradation rather that the synthesis of collagen. We performed zymopgraphy staining on the aortic lesions which measures gelatinase activity (mainly Mmp2 and Mmp9). No difference in gelatinase activity was observed between both groups (Figure 3H).

Figure 3: Peritoneal macrophages of Kdm6b deleted mice express more Tgfb1. Relative mRNA expression in

unstimulated PEMs of (A)Tgfb1 (B) Mmps and (C) Timps. Relative mRNA expression of (D) Tgfb1 (E) Mmp2 and (F) Timp3 in aortic arches of mice. Expression levels were normalized to two housekeeping genes. (G) Collagen

production by VSMCs incubated for 24h with supernatants of Kdm6bwt or Kdm6bdel BMDMs. BMDMs were stimulated for 24h with oxLDL or acLDL (both 50ug/ml) or left unstimulated. (H) Gelatinase activity as

percentage of total lesion area. Data represent mean ± SEM *P<0.05; **P<0.01; ***P<0.001.

117

Figure 4: Leukocyte chemotaxis pathway is upregulated in Kdm6bdel mice. (A) Heatmap of significantly up- and downregulated genes in unstimulated Kdm6bwt and Kdm6bdel foam cells based on RNA sequencing analysis. Bonferroni adjusted p < 0.05 and RPKM >1 in at least one group. (B) Significantly upregulated genes in Kdm6b

deficient foam cells compared with Kdm6bwt cells. (C) Top 10 pathways and GO-terms of upregulated genes from (B) RPKM: Reads per kilobase per million mapped reads.

Pathway analysis shows upregulation of leukocyte chemotaxis

Since the mechanism by which myeloid kdm6b contributes to lesion development remained indefinite, we performed pathway analysis on upregulated genes of kdm6b

(13)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 118PDF page: 118PDF page: 118PDF page: 118

118

deficient foam cells in order to identify additional regulated pathways (19). This revealed that 43 genes were significantly (p < 0.05) upregulated in unstimulated Kdm6bdel foam cells compared with Kdm6bwt cells (Figure 4A-B). Pathway analysis on

these upregulated genes showed that leukocyte chemotaxis was the top significantly upregulated pathway in Kdm6b deficient foam cells (q-value = 10-3) (Figure 4C). However, macrophage and neutrophil content was similar between groups in 9 week old lesions. This led to the hypothesis that the rate of development of atherosclerotic lesions might be different between both groups of mice resulting in more advanced atherosclerosis in the absence of myeloid Kdm6b. Correlating plaque size with macrophages and collagen revealed that both correlated with plaque size in Kdm6bwt and Kdm6bdel transplanted mice (Figure 5A-B). However, the slope for both

macrophages and collagen was significantly different in Kdm6bdel mice compared to

wildtype. Larger lesions in Kdm6bdel mice thus seem to contain less macrophages and more collagen further supporting the notion that lesion progression is faster in the absence of Kdm6b.

Figure 5: Macrophage and collagen development is different in Kdm6bdel mice. (A) Correlation of plaque size per valve with macrophages (MOMA-2) for Kdm6bwt and Kdm6bdel transplanted mice. (B) Correlation of plaque size per valve with collagen (Sirius red) for Kdm6bwt and Kdm6bdel transplanted mice. Linear regression is used to statistically test differences between both slopes.

Discussion

We here showed that myeloid deficiency of Kdm6b results in more advanced atherosclerotic lesions. Although lesion size is similar, collagen content and necrotic area were significantly enhanced. We previously reported that peritoneal foam cells of

Kdm6bdel transplanted mice have reduced expression of pro-fibrotic pathways in

119

macrophages (19). While pro-fibrotic genes and pathways are reduced in Kdm6bdel

foam cells, collagen content is enhanced in atherosclerotic lesions of Kdm6bdel

transplanted mice. This suggests that the reduced pro-fibrotic phenotype of Kdm6b deficient macrophages is not responsible for the overall collagen content in atherosclerotic lesions. This does not rule out the possibility that the Kdm6b deficient macrophages within the atherosclerotic lesion are less fibrotic. Likely, other cells and mechanisms are stronger regulators of collagen deposition in atherosclerosis.

Smooth muscle cells (SMCs) are the main source of collagen in atherosclerotic plaques (20). Although in our study only myeloid cells lack Kdm6b, the interaction between myeloid cells and SMCs, or secreted factors from neutrophils and macrophages could strongly influence the phenotype of SMCs. Secreted growth factors like platelet-derived growth factors (PDGF), fibroblast growth factor (FGF) and TGF-β are important stimuli for these SMCs. These factors induce proliferation and migration of SMCs, but also switches these cells from quiescent phenotype to an active and synthetic state enhancing extracellular (ECM) deposition (23). Although pro-fibrotic genes and pathways are reduced in Kdm6b deficient foam cells we found Tgfb1 to be upregulated in these foam cells. Nevertheless analysis on the aortic arch did not show any difference of Tgfb1 expression overall. The same holds true for Mmp2, which is an important enzyme in the degradation of collagen (24). Besides degradation of collagen, knockout studies also showed that lack of Mmp2 results in reduced atherosclerosis in ApoE-deficient mice (25). Kdm6bdel foam cells display reduced

expression of Mmp2, but again no difference in Mmp2 expression was observed in the aortic arch. The fact that we do find expression differences in the foam cells, but not in the overall lesions can be due to the fact that only myeloid cells lack Kdm6b. qPCR was performed on 9 week old lesions and at this stage 60% of the lesions consists of macrophages. Lesions contain endothelial cells, smooth muscle cells, collagen, necrosis and adaptive immune cells and it is therefore reasonable that the differences in expression are masked by those cells. We also tested Mmp2 activity in the plaque by performing a gelatinase activity assay on the lesions. No difference in gelatinase activity was observed.

No clear candidate genes or pathways in Kdm6bdel macrophages were responsible for the advanced lesion phenotype in the plaque. Pathway analysis on upregulated genes in Kdm6bdel mice showed that leukocyte chemotaxis was significantly enhanced.

Interestingly when stained for macrophages and neutrophils in the 9 week old plaques no difference was observed. It is known that macrophages mainly infiltrate in early lesions and that infiltration into pre-existing advanced lesions with a fibrous cap is

(14)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 119PDF page: 119PDF page: 119PDF page: 119

118

deficient foam cells in order to identify additional regulated pathways (19). This revealed that 43 genes were significantly (p < 0.05) upregulated in unstimulated Kdm6bdel foam cells compared with Kdm6bwt cells (Figure 4A-B). Pathway analysis on

these upregulated genes showed that leukocyte chemotaxis was the top significantly upregulated pathway in Kdm6b deficient foam cells (q-value = 10-3) (Figure 4C). However, macrophage and neutrophil content was similar between groups in 9 week old lesions. This led to the hypothesis that the rate of development of atherosclerotic lesions might be different between both groups of mice resulting in more advanced atherosclerosis in the absence of myeloid Kdm6b. Correlating plaque size with macrophages and collagen revealed that both correlated with plaque size in Kdm6bwt and Kdm6bdel transplanted mice (Figure 5A-B). However, the slope for both

macrophages and collagen was significantly different in Kdm6bdel mice compared to

wildtype. Larger lesions in Kdm6bdel mice thus seem to contain less macrophages and more collagen further supporting the notion that lesion progression is faster in the absence of Kdm6b.

Figure 5: Macrophage and collagen development is different in Kdm6bdel mice. (A) Correlation of plaque size per valve with macrophages (MOMA-2) for Kdm6bwt and Kdm6bdel transplanted mice. (B) Correlation of plaque size per valve with collagen (Sirius red) for Kdm6bwt and Kdm6bdel transplanted mice. Linear regression is used to statistically test differences between both slopes.

Discussion

We here showed that myeloid deficiency of Kdm6b results in more advanced atherosclerotic lesions. Although lesion size is similar, collagen content and necrotic area were significantly enhanced. We previously reported that peritoneal foam cells of

Kdm6bdel transplanted mice have reduced expression of pro-fibrotic pathways in

119

macrophages (19). While pro-fibrotic genes and pathways are reduced in Kdm6bdel

foam cells, collagen content is enhanced in atherosclerotic lesions of Kdm6bdel

transplanted mice. This suggests that the reduced pro-fibrotic phenotype of Kdm6b deficient macrophages is not responsible for the overall collagen content in atherosclerotic lesions. This does not rule out the possibility that the Kdm6b deficient macrophages within the atherosclerotic lesion are less fibrotic. Likely, other cells and mechanisms are stronger regulators of collagen deposition in atherosclerosis.

Smooth muscle cells (SMCs) are the main source of collagen in atherosclerotic plaques (20). Although in our study only myeloid cells lack Kdm6b, the interaction between myeloid cells and SMCs, or secreted factors from neutrophils and macrophages could strongly influence the phenotype of SMCs. Secreted growth factors like platelet-derived growth factors (PDGF), fibroblast growth factor (FGF) and TGF-β are important stimuli for these SMCs. These factors induce proliferation and migration of SMCs, but also switches these cells from quiescent phenotype to an active and synthetic state enhancing extracellular (ECM) deposition (23). Although pro-fibrotic genes and pathways are reduced in Kdm6b deficient foam cells we found Tgfb1 to be upregulated in these foam cells. Nevertheless analysis on the aortic arch did not show any difference of Tgfb1 expression overall. The same holds true for Mmp2, which is an important enzyme in the degradation of collagen (24). Besides degradation of collagen, knockout studies also showed that lack of Mmp2 results in reduced atherosclerosis in ApoE-deficient mice (25). Kdm6bdel foam cells display reduced

expression of Mmp2, but again no difference in Mmp2 expression was observed in the aortic arch. The fact that we do find expression differences in the foam cells, but not in the overall lesions can be due to the fact that only myeloid cells lack Kdm6b. qPCR was performed on 9 week old lesions and at this stage 60% of the lesions consists of macrophages. Lesions contain endothelial cells, smooth muscle cells, collagen, necrosis and adaptive immune cells and it is therefore reasonable that the differences in expression are masked by those cells. We also tested Mmp2 activity in the plaque by performing a gelatinase activity assay on the lesions. No difference in gelatinase activity was observed.

No clear candidate genes or pathways in Kdm6bdel macrophages were responsible for the advanced lesion phenotype in the plaque. Pathway analysis on upregulated genes in Kdm6bdel mice showed that leukocyte chemotaxis was significantly enhanced.

Interestingly when stained for macrophages and neutrophils in the 9 week old plaques no difference was observed. It is known that macrophages mainly infiltrate in early lesions and that infiltration into pre-existing advanced lesions with a fibrous cap is

(15)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 120PDF page: 120PDF page: 120PDF page: 120

120

largely impaired (26). These 9 week old lesions are already at a late stage and the fact that also necrosis is enhanced in Kdm6bdel mice, led to the hypothesis that during

lesion initiation migration of myeloid cells is enhanced. We correlated plaque size with macrophages and collagen and found that the slope for both macrophages and collagen was significantly different for Kdm6bdel mice. Macrophages were more present in smaller lesions and reduced in bigger lesions. For collagen this was reversed. This supports the idea that the lesions initiate faster by the infiltration of monocytes in the end resulting in advanced atherosclerosis. We propose that the progression of lesions is different. To really test this hypothesis and prove that the macrophage content is altered in early lesions, the same experiments should be performed at an earlier time point.

In conclusion, myeloid Kdm6b deficiency switches atherosclerosis to more advanced lesions with enhanced collagen deposition and necrosis. We hypothesize that this due to a difference in lesion progression, where Kdm6bdel lesions initiate faster by

infiltration of macrophages, thereby leading to a more progressive and advanced atherosclerosis.

Summary points

Collagen content is enhanced in atherosclerotic lesions of mice lacking myeloid Kdm6b.

Necrosis is enhanced in atherosclerotic lesions of Kdm6b deficient mice. Myeloid Kdm6b deficiency results in advanced atherosclerosis in mice. Kdm6b myeloid deficiency has no effect on atherosclerotic lesion size.

Acknowledgements

This work was mainly supported by The Netherlands Heart Foundation (CVON 2011/ B019: Generating the best evidence-based pharmaceutical targets for atherosclerosis [GENIUS]). Jan Van den Bossche received a Junior Postdoc grant from the Netherlands Heart Foundation (2013T003) and a VENI grant from ZonMW (91615052). Menno PJ de Winther is an established investigator of the Netherlands Heart Foundation (2007T067), is supported by a Netherlands Heart Foundation grant (2010B022), Spark-Holding BV (2015B002), the European Union (ITN-grant EPIMAC) and holds an AMC-fellowship. Menno PJ de Winther and Esther Lutgens are both supported by REPROGRAM (EU Horizon 2020). The generation of Kdm6b (Jmjd3) fl/fl mice was supported by the DFG (SFB834, project B5) to Stefanie Dimmeler.

121

References

1. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nature reviews Immunology. 2013;13(10):709-21.

2. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341-55. 3. Tabas I, Bornfeldt KE. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. Circulation research. 2016;118(4):653-67.

4. Glass CK, Natoli G. Molecular control of activation and priming in macrophages. Nature immunology. 2016;17(1):26-33.

5. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14-20.

6. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014;40(2):274-88.

7. Neele AE, Van den Bossche J, Hoeksema MA, de Winther MP. Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis. Eur J Pharmacol. 2015;763(Pt A):79-89.

8. Hoeksema MA, de Winther MP. Epigenetic Regulation of Monocyte and Macrophage Function. Antioxidants & redox signaling. 2016.

9. Di Croce L, Helin K. Transcriptional regulation by Polycomb group proteins. Nature structural & molecular biology. 2013;20(10):1147-55.

10. Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J, et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature. 2007;449(7163):731-4.

11. Chen S, Ma J, Wu F, Xiong LJ, Ma H, Xu W, et al. The histone H3 Lys 27 demethylase JMJD3 regulates gene expression by impacting transcriptional elongation. Genes & development. 2012;26(12):1364-75.

12. De Santa F, Narang V, Yap ZH, Tusi BK, Burgold T, Austenaa L, et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 2009;28(21):3341-52.

13. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell. 2007;130(6):1083-94.

14. Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, Allen RM, et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood. 2009;114(15):3244-54.

15. Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012;488(7411):404-8. 16. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature immunology. 2010;11(10):936-44.

17. Van den Bossche J, Neele AE, Hoeksema MA, de Winther MP. Macrophage polarization: the epigenetic point of view. Curr Opin Lipidol. 2014;25(5):367-73.

18. Yan Q, Sun L, Zhu Z, Wang L, Li S, Ye RD. Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages. Cell Signal. 2014;26(9):1783-91.

19. Neele AE, Prange KH, Hoeksema MA, van der Velden S, Lucas T, Dimmeler S, et al. Macrophage Kdm6b controls the pro-fibrotic transcriptome signature of foam cells. Epigenomics. 2017;9(4):383-91.

20. Rekhter MD. Collagen synthesis in atherosclerosis: too much and not enough. Cardiovascular research. 1999;41(2):376-84.

21. Ohtani K, Zhao C, Dobreva G, Manavski Y, Kluge B, Braun T, et al. Jmjd3 controls mesodermal and cardiovascular differentiation of embryonic stem cells. Circulation research. 2013;113(7):856-62.

22. Kanters E, Pasparakis M, Gijbels MJ, Vergouwe MN, Partouns-Hendriks I, Fijneman RJ, et al. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 2003;112(8):1176-85.

23. Rensen SS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 2007;15(3):100-8.

24. Newby AC, George SJ, Ismail Y, Johnson JL, Sala-Newby GB, Thomas AC. Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. Thrombosis and haemostasis. 2009;101(6):1006-11. 25. Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arteriosclerosis, thrombosis, and vascular biology. 2006;26(5):1120-5.

(16)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 121PDF page: 121PDF page: 121PDF page: 121

120

largely impaired (26). These 9 week old lesions are already at a late stage and the fact that also necrosis is enhanced in Kdm6bdel mice, led to the hypothesis that during

lesion initiation migration of myeloid cells is enhanced. We correlated plaque size with macrophages and collagen and found that the slope for both macrophages and collagen was significantly different for Kdm6bdel mice. Macrophages were more present in smaller lesions and reduced in bigger lesions. For collagen this was reversed. This supports the idea that the lesions initiate faster by the infiltration of monocytes in the end resulting in advanced atherosclerosis. We propose that the progression of lesions is different. To really test this hypothesis and prove that the macrophage content is altered in early lesions, the same experiments should be performed at an earlier time point.

In conclusion, myeloid Kdm6b deficiency switches atherosclerosis to more advanced lesions with enhanced collagen deposition and necrosis. We hypothesize that this due to a difference in lesion progression, where Kdm6bdel lesions initiate faster by

infiltration of macrophages, thereby leading to a more progressive and advanced atherosclerosis.

Summary points

Collagen content is enhanced in atherosclerotic lesions of mice lacking myeloid Kdm6b.

Necrosis is enhanced in atherosclerotic lesions of Kdm6b deficient mice. Myeloid Kdm6b deficiency results in advanced atherosclerosis in mice. Kdm6b myeloid deficiency has no effect on atherosclerotic lesion size.

Acknowledgements

This work was mainly supported by The Netherlands Heart Foundation (CVON 2011/ B019: Generating the best evidence-based pharmaceutical targets for atherosclerosis [GENIUS]). Jan Van den Bossche received a Junior Postdoc grant from the Netherlands Heart Foundation (2013T003) and a VENI grant from ZonMW (91615052). Menno PJ de Winther is an established investigator of the Netherlands Heart Foundation (2007T067), is supported by a Netherlands Heart Foundation grant (2010B022), Spark-Holding BV (2015B002), the European Union (ITN-grant EPIMAC) and holds an AMC-fellowship. Menno PJ de Winther and Esther Lutgens are both supported by REPROGRAM (EU Horizon 2020). The generation of Kdm6b (Jmjd3) fl/fl mice was supported by the DFG (SFB834, project B5) to Stefanie Dimmeler.

121

References

1. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nature reviews Immunology. 2013;13(10):709-21.

2. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341-55. 3. Tabas I, Bornfeldt KE. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. Circulation research. 2016;118(4):653-67.

4. Glass CK, Natoli G. Molecular control of activation and priming in macrophages. Nature immunology. 2016;17(1):26-33.

5. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14-20.

6. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014;40(2):274-88.

7. Neele AE, Van den Bossche J, Hoeksema MA, de Winther MP. Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis. Eur J Pharmacol. 2015;763(Pt A):79-89.

8. Hoeksema MA, de Winther MP. Epigenetic Regulation of Monocyte and Macrophage Function. Antioxidants & redox signaling. 2016.

9. Di Croce L, Helin K. Transcriptional regulation by Polycomb group proteins. Nature structural & molecular biology. 2013;20(10):1147-55.

10. Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J, et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature. 2007;449(7163):731-4.

11. Chen S, Ma J, Wu F, Xiong LJ, Ma H, Xu W, et al. The histone H3 Lys 27 demethylase JMJD3 regulates gene expression by impacting transcriptional elongation. Genes & development. 2012;26(12):1364-75.

12. De Santa F, Narang V, Yap ZH, Tusi BK, Burgold T, Austenaa L, et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 2009;28(21):3341-52.

13. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell. 2007;130(6):1083-94.

14. Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, Allen RM, et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood. 2009;114(15):3244-54.

15. Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012;488(7411):404-8. 16. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature immunology. 2010;11(10):936-44.

17. Van den Bossche J, Neele AE, Hoeksema MA, de Winther MP. Macrophage polarization: the epigenetic point of view. Curr Opin Lipidol. 2014;25(5):367-73.

18. Yan Q, Sun L, Zhu Z, Wang L, Li S, Ye RD. Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages. Cell Signal. 2014;26(9):1783-91.

19. Neele AE, Prange KH, Hoeksema MA, van der Velden S, Lucas T, Dimmeler S, et al. Macrophage Kdm6b controls the pro-fibrotic transcriptome signature of foam cells. Epigenomics. 2017;9(4):383-91.

20. Rekhter MD. Collagen synthesis in atherosclerosis: too much and not enough. Cardiovascular research. 1999;41(2):376-84.

21. Ohtani K, Zhao C, Dobreva G, Manavski Y, Kluge B, Braun T, et al. Jmjd3 controls mesodermal and cardiovascular differentiation of embryonic stem cells. Circulation research. 2013;113(7):856-62.

22. Kanters E, Pasparakis M, Gijbels MJ, Vergouwe MN, Partouns-Hendriks I, Fijneman RJ, et al. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 2003;112(8):1176-85.

23. Rensen SS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 2007;15(3):100-8.

24. Newby AC, George SJ, Ismail Y, Johnson JL, Sala-Newby GB, Thomas AC. Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. Thrombosis and haemostasis. 2009;101(6):1006-11. 25. Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arteriosclerosis, thrombosis, and vascular biology. 2006;26(5):1120-5.

(17)

515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele 515552-L-bw-neele Processed on: 1-12-2017 Processed on: 1-12-2017 Processed on: 1-12-2017

Processed on: 1-12-2017 PDF page: 122PDF page: 122PDF page: 122PDF page: 122

122

26. Ye D, Zhao Y, Hildebrand RB, Singaraja RR, Hayden MR, Van Berkel TJ, et al. The dynamics of macrophage infiltration into the arterial wall during atherosclerotic lesion development in low-density lipoprotein receptor knockout mice. The American journal of pathology. 2011;178(1):413-22.

Referenties

GERELATEERDE DOCUMENTEN

Quantum Levy Flights and Multifractality of Dipolar Excitations in a Random System.. Deng, X.; Altshuler, B.L.; Shlyapnikov, G.V.;

One participant (transgender man, 20, single, gay) discussed having future children through traditional intercourse by say- ing, ‘‘I would like to experience pregnancy and have

Segeth has a rich pedagogical experience due to the many decades that he worked at several Czech universities, such as the Faculty of Mathematics and Physics and Faculty of Sciences

(su h as hara teristi varieties, duality) to the rational Cherednik algebra.. One of them is related to F ourier transform while the other, mu

Despite failing to detect MPGES1 positive B cells in the rheumatoid tissue, we showed that SF and PB B cells from RA patients are able of upregulating MPGES1 and COX-2 upon in

Parity effects in the scaling of block entanglement in gapless spin chains.. Calabrese, P.; Campostrini, M.; Essler, F.;

Note: To cite this publication please use the final published version

The study described in this thesis was supported by a grant of the Netherlands Heart Foundation (NHF-2001B164) and was performed at the Division of Biopharmaceutics,